中西医结合治疗对糖尿病肾病的临床效果观察
2020-09-26王瑛璞
王瑛璞


[摘要] 目的 探讨中西医结合治疗对糖尿病肾病的临床效果。 方法 选取2018年8月—2019年2月期间该院收治的68例糖尿病肾病患者,根据治疗方式分为降糖益肾汤组和西药组,各34例。西药组采用西药(厄贝沙坦)治疗,降糖益肾汤组在西药组基础上增加降糖益肾汤治疗, 观察两组患者血糖及肾功能指标改善情况,并对比两组不良反应情况。 结果 降糖益肾汤组治疗12周后空腹血糖(4.38±1.24)mmol/L和糖化血红蛋白(7.48±0.98)%指标水平显著低于西药组(5.68±1.14)mmol/L、(8.37±1.02)%,差异有统计学意义(P<0.05)。降糖益肾汤组治疗12周后血肌酐(192.23±42.03)μmol/L、24 h尿蛋白定量(0.26±0.13)g/24 h指标水平均显著低于西药组(286.31±52.71)μmol/L、(0.42±0.15)g/24 h,差异有统计学意义(P<0.05)。 结论 厄贝沙坦+降糖益肾汤治疗可有效改善糖尿病肾病患者肾功能,同时提升降糖效果,该中西医结合方案疗法可靠,值得推广借鉴。
[关键词] 糖尿病肾病;中西医结合;尿蛋白;血糖;肾功能
[中图分类号] R587.2;R692.9 [文献标识码] A [文章编号] 1672-4062(2020)06(b)-0191-03
[Abstract] Objective To explore the clinical effect of integrated traditional Chinese and western medicine treatment on diabetic nephropathy. Methods A total of 68 patients with diabetic nephropathy admitted to our hospital from August 2018 to February 2019 were selected and divided into Jiangtang Yishen Decoction group and Western medicine group according to the treatment method, 34 cases each. The western medicine group was treated with western medicine (irbesartan), and the Jiangtang Yishen Decoction group added Jiangtang Yishen Decoction to the western medicine group. Observe the improvement of blood glucose and renal function indexes of the two groups, and compare the adverse reactions of the two groups. Results The levels of fasting blood glucose (4.38±1.24)mmol/L and glycated hemoglobin (7.48±0.98)% in the Jiangtang Yishen Decoction group were significantly lower than those in the Western medicine group (5.68±1.14)mmol/L, (8.37±1.02)%, the difference was statistically significant (P<0.05). The blood creatinine (192.23±42.03)μmol/L and 24 h urine protein quantitative (0.26±0.13)g/24 h indexes of Jiangtang Yishen Decoction group were significantly lower than those of the Western medicine group(286.31±52.71)μmol/L, (0.42±0.15)g/24 h, the difference is statistically significant(P<0.05). Conclusion Irbesartan + Jiangtang Yishen Decoction can effectively improve the renal function of patients with diabetic nephropathy, and at the same time improve the hypoglycemic effect. This combination of traditional Chinese and western medicine is reliable and worth promoting.
[Key words] Diabetic nephropathy; integrated Chinese and Western medicine; Urine protein; Blood glucose; Renal function
我國是糖尿病大国,患病群体十分庞大,而糖尿病并发症也成为重要医学及社会问题,必须进一步提升相关并发症防治水平。糖尿病肾病为糖尿病患者的高发并发症,危害性大,直接影响患者生命安全,必须尽早干预治疗。西药治疗糖尿病肾病的疗效有限,而中医在相关证候治疗中积累了丰富经验,降糖益肾汤等方剂临床应用较多,但其联合西药的辅助治疗效果尚有待明确[1]。为此,该研究选取2018年8月—2019年2月期间该院收治的68例糖尿病肾病患者,对比分析了厄贝沙坦+降糖益肾汤治疗的临床疗效,现报道如下。
1 资料与方法
1.1 一般资料
选取该院收治的68例糖尿病肾病患者,根据治疗方式分为降糖益肾汤组和西药组,各34例。两组患者均存在2型糖尿病史,行生化检查、肾功能检查及影像学检查确诊为糖尿病肾病。降糖益肾汤组,男20例,女14例;年龄45~72岁,平均(58.46±13.56)岁;病程1~4年,平均(2.89±1.03)年。……
